Atlas Trials

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

Clinical trial NCT00313976 · WITHDRAWN

Trial details

NCT number
NCT00313976
Sponsor
Bayer
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Sclerosis
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.